Cancer detection: Seeking signals in blood
Authors:
- 23 February 2018
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 359 (6378) , 866-867
Abstract
Combining gene mutations and protein biomarkers for earlier detection and localizationKeywords
This publication has 15 references indexed in Scilit:
- Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive CholangiocarcinomaCancer Discovery, 2017
- Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screeningCA: A Cancer Journal for Clinicians, 2017
- Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer DetectionCell, 2017
- An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinomaProceedings of the National Academy of Sciences, 2017
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-OriginCell, 2016
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast CancerNew England Journal of Medicine, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- The Evolving War on CancerCell, 2011
- Feasibility Study for Collection of HER2 Data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Central Cancer RegistriesCancer Epidemiology, Biomarkers & Prevention, 2010